Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short-term Investments: 2023-2025

Historic Short-term Investments for Collegium Pharmaceutical (COLL) over the last 3 years, with Sep 2025 value amounting to $135.8 million.

  • Collegium Pharmaceutical's Short-term Investments rose 67.62% to $135.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.8 million, marking a year-over-year increase of 67.62%. This contributed to the annual value of $92.2 million for FY2024, which is 28.77% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Short-term Investments of $135.8 million as of Q3 2025, which was up 29.54% from $104.8 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Short-term Investments peaked at $135.8 million during Q3 2025, and registered a low of $41.7 million during Q2 2023.
  • In the last 3 years, Collegium Pharmaceutical's Short-term Investments had a median value of $90.8 million in 2024 and averaged $86.3 million.
  • Data for Collegium Pharmaceutical's Short-term Investments shows a peak YoY skyrocketed of 136.66% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Collegium Pharmaceutical's Short-term Investments stood at $71.6 million in 2023, then grew by 28.77% to $92.2 million in 2024, then soared by 67.62% to $135.8 million in 2025.
  • Its last three reported values are $135.8 million in Q3 2025, $104.8 million for Q2 2025, and $101.6 million during Q1 2025.